Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2025-12-16 @ 11:53 PM
Study NCT ID:
NCT04802317
Status:
None
Last Update Posted:
2023-12-06 00:00:00
First Post:
2021-03-12 00:00:00
Brief Title:
Intestinal Microbiota in COPD and Asthma
Sponsor:
National Medical Research Center for Therapy and Preventive Medicine
Organization:
National Medical Research Center for Therapy and Preventive Medicine
Study Overview
Official Title:
Identifying the Relationship Between the Features of the Composition and Functioning of the Intestinal Microbiota With the Course of Chronic Obstructive Pulmonary Disease and Asthma (MicrObAs)
Status:
None
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MicrObAs
Brief Summary:
The patients from "Biobank of blood and feces for the development of a clinical and biological platform as a basis for an innovative approach to the prevention of chronic non-infectious diseases based on the composition of the intestinal microbiota" study will be included (cross-sectional study). The protocol of the above study included the assessment of socio-demographic, anthropometric data, clinical blood pressure (BP), ECG, blood tests, fecal microbiota studies, spirometry data, diet questionnaire. ABPM, HBP, other questionnaires (mMRC, CAT, ACQ-5, GMBQ) will be added to initial data (=visit 1). Than the four visits (2-5th visits) in 3 each months will be performed to assess respiratory symptoms, exacerbations of COPD/asthma, respiratory infections, therapy, BP, and other parameters. The standard statistical methods will be used.
Detailed Description:
The patients from Biobank of blood and feces for the development of a clinical and biological platform as a basis for an innovative approach to the prevention of chronic non-infectious diseases based on the composition of the intestinal microbiota study will be included cross-sectional study The protocol of the above study included the assessment of socio-demographic anthropometric data clinical blood pressure BP ECG blood tests fecal microbiota studies spirometry data diet questionnaire ABPM HBP other questionnaires mMRC CAT ACQ-5 GMBQ will be added to initial data visit 1 Than the four visits 2-5th visits in 3 each months will be performed to assess respiratory symptoms exacerbations of COPDasthma respiratory infections therapy BP and other parameters The standard statistical methods will be used
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None